News
KPRDO acknowledges Emcure’s positive response on exclusive stockist appointment for special category sales: Nandita ...
Emcure Pharma stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5 as the company ...
The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...
Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...
Pharma giants like Cipla, Glenmark, and Emcure are stepping into the booming skincare market, challenging beauty brands with ...
Emcure Pharmaceuticals partners with Sanofi India to distribute and promote oral anti-diabetic products in India.
Emcure Pharmaceuticals and Sanofi India have entered into a distribution agreement to promote Sanofi's oral anti-diabetic products, Amaryl and Cetapin, across India.
Emcure Pharmaceuticals and Sanofi India have entered in a partnership to distribute and promote Sanofi’s oral anti-diabetic ...
Emcure Pharmaceuticals and Sanofi India announce exclusive distribution agreement for Sanofi's oral anti-diabetic products in ...
Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...
India's pharma and healthcare sector saw 57 deals worth $1.30 billion in the quarter ending June. This reflects a drop ...
Pune: Emcure Pharma has announced the appointment of R.S. Vasan as President - India Business and Senior Management Personnel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results